BUZZ - PepsiCo's stock rises as the company predicts annual revenue will reach the upper end of its guidance range
路透社2026/10/08 10:26October 8 - * Snack and carbonated beverage giant PepsiCo (PEP.O) saw its shares rise by 2% in pre-market trading, quoted at $125.32. ** The beverage manufacturer stated it expects full-year revenue to reach the upper end of the previously forecasted range of 4% to 6%. ** It now anticipates annual core earnings per share growth of 1% to 2% at constant currency, compared to the previously forecasted lower end of the 4% to 6% range. ** Third-quarter net revenue came in at $25.27 billions, surpassing analyst expectations of $24.96 billions compiled by LSEG. ** Core earnings per share grew 2% in the third quarter to $2.34. ** CEO Ramon Laguarta stated: "We are currently formulating further structural cost-saving measures, which will be implemented in the coming months." ** As of the previous session close, the stock was down 13.8% year-to-date. (For the convenience of non-English speakers, Reuters provides automated translations of its reports into several other languages. Since automated translations may contain errors or lack necessary contextual information, Reuters does not guarantee the accuracy of these automated text versions. They are provided solely for reader convenience. Reuters assumes no responsibility for any damage or loss arising from the use of automated translations.)
October 8 - * Snack and soft drink giant PepsiCo (PEP.O) shares rose 2% in pre-market trading, quoted at $125.32
** The beverage manufacturer said it expects (link) full-year revenue to reach the upper end of its previous forecast range of 4% to 6%
** Core annual earnings per share at constant exchange rates are expected to grow 1% to 2%, down from the previous forecast at the lower end of the 4% to 6% range
** Third-quarter net revenue was $25.27 billion, beating analysts’ expectations of $24.96 billion compiled by LSEG
** Third-quarter core earnings per share rose 2% to $2.34
** CEO Ramon Laguarta said: "We are currently formulating further structural cost reduction measures, which will be implemented in the coming months"
** As of the close of the previous trading day, the stock had fallen 13.8% year-to-date
(To facilitate non-native English speakers, Reuters offers automated translation of its reports into several other languages. Because automated translation may be inaccurate or fail to convey necessary context, Reuters does not guarantee the accuracy of automated translation texts and provides them only for reader convenience. Reuters assumes no liability for any damage or loss resulting from the use of automated translation tools.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Canaccord Genuity: Lowers Oklo's target price to $66
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss
Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.
Crypto prices
More
